Silva, DavidMoreira, FernandoSantos, MarleneMoreira, Fernando2025-10-172025-10-172025-06-13Silva, D., Moreira, F., & Santos, M. (2025). Efficacy and safety of Tocilizumab in the treatment of Rheumatoid Arthritis: An umbrella review. 34 (1), 10, 11. https://www.mdpi.com/2673-9992/34/1/1http://hdl.handle.net/10400.22/30628Tocilizumab (TCZ) is a humanized immunoglobulin G1 monoclonal antibody that targets and inhibits the interleukin-6 (IL-6) receptor. As a selective inhibitor of this cytokine, TCZ offers a targeted approach in managing inflammatory conditions. Given its specificity and potential therapeutic benefits, this article aims to provide a comprehensive summary of the efficacy and safety of TCZ in the treatment of RA.engImmune systemTumor immunologyAutoimmune diseaseconference paper